Single cell profiling of functionally cured Chronic Hepatitis B patients reveals the emergence of activated innate and an altered adaptive immune response in the intra-hepatic environment
Balakrishnan Chakrapani NarmadaiD, Atefeh KhakpooriD, Niranjan ShirgaonkariD, Sriram NarayananiD, Pauline Poh Kim AwiD, Malay SinghiD, Kok Haur OngiD, Collins Oduor OwinoiD, Jane Wei Ting Ng, Hui-Chuing Yew, Nu Soibah Binte Mohamed Nasir, Veonice Bijin Au, Reina SngiD, Nivashini Kaliaperumal, Htet Htet Toe Wai Khine, Hui Xin Ng, Su Li Chia, Cindy Xin Yi Seah, Myra HJ. Alnawaz, Chris Lee Yoon Wai, Amy Yuh Ling Tay, Weimiao YuiD, John Edward Connolly, Giridharan PeriyasamyiD, Seng Gee LimiD, Ramanuj DasGuptaiD
Abstract
Hepatitis B surface antigen (HBsAg) loss or functional cure (FC), is considered the desirable therapeutic outcome for chronic hepatitis B (CHB) patients. However, the immuno-pathological biomarkers and underlying mechanisms remain unclear. Here we present a comprehensive single cell-transcriptomic atlas together with immune-phenotyping of disease-associated cell states (DACS) isolated from intra-hepatic tissue and matched PBMCs of either CHB or FC patients. We find that the intra-hepatic environment displays specific cell identities and molecular signatures that are distinct from PBMCs. FC is associated with emergence of an altered adaptive immune response marked by CD4 cytotoxic T lymphocytes (CD4-CTLs), and an activated innate response represented by liver-resident natural killer (LR-NK) cells. Overall, these findings provide novel insights into immuno-pathological cell states associated with FC that could serve as prognostic biomarkers.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Clinical cure of chronic hepatitis B is dependent on activation and perpetuation of robust CD4+ T cell responses
Jillian M. Jespersen, Lia Avanesyan, … Jody L. Baron·bioRxiv·Sep 29, 2025
- Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers predicting HBsAg loss
- B cell transcriptomics reveals lasting dysregulation and rapid decline of protective memory after hepatitis C cure
Fang Chen, Erick Giang, … Mansun Law·bioRxiv·Oct 24, 2025
- Heterogeneous T cell responses across Hepatitis B virus clinical phases revealed by rapid whole-blood HBV T cell analysis
Nina Le Bert, Apostolos Koffas, … Patrick T.F. Kennedy·bioRxiv·Feb 11, 2025
- Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines
Jonida Kokiçi, Helena Arellano-Ballestero, … Dimitra Peppa·CytotherapyPeer-reviewed·Oct 25, 2025
- Peripheral Natural Killer cells from chronic hepatitis B patients display molecular hallmarks of T cell exhaustion
M. Marotel, M. Villard, … A. Marcais·bioRxiv·Jun 16, 2020